LEO 90105

DRUG3 trials

Sponsors

LEO Pharma

Conditions

HealthyPsoriasis Vulgaris

Phase 1

A Study Evaluating Skin Irritation, Phototoxicity and Safety After Administration of LEO 90105 on Intact Skin of Healthy Japanese Male Subjects

CompletedNCT01293357

LEO PharmaHealthy

Start: 2010-12-31End: 2010-12-31Updated: 2025-02-24

A Study Evaluating the Safety of LEO 90105 and Its Vehicle, After Multiple Administration on Intact Skin of Healthy Japanese Male Subjects

CompletedNCT01293383

LEO PharmaHealthy

Start: 2011-03-31End: 2011-03-31Updated: 2025-02-24

The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Extensive Psoriasis Vulgaris

CompletedNCT01768013

LEO PharmaPsoriasis Vulgaris

Start: 2012-07-31End: 2012-10-31Updated: 2025-03-12